Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis
Condition: Dermatomyositis, Adult Type Intervention: Drug: Itolizumab Sponsor: Biotech Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials